This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Avian myelocytomatosis virus | |
|---|---|
| Name | Avian myelocytomatosis virus |
| Virus group | Retroviridae |
| Genus | Alpharetrovirus |
| Species | Myelocytomatosis virus |
| Hosts | Birds |
| Diseases | Myelocytomatosis, neoplasia |
Avian myelocytomatosis virus is a member of the Alpharetrovirus genus that causes myelocytomatosis and related neoplasms in avian species, notably poultry and wild birds. The virus has been studied extensively in relation to tumor biology, oncogenes, and vaccine development, influencing work at institutions such as the Rockefeller University, Johns Hopkins University, and the Roslin Institute. It has played a role in historical and contemporary research connected to figures and organizations including Harvard University, Cold Spring Harbor Laboratory, and researchers like Howard Temin and Hiroaki Mitsuya.
The virus is classified within the family Retroviridae and the genus Alpharetrovirus, alongside related taxa investigated at centers such as Institut Pasteur and Max Planck Society. Taxonomic placement has been refined using approaches from International Committee on Taxonomy of Viruses standards and comparative studies published by laboratories at Massachusetts Institute of Technology and University of Cambridge. Subtypes and strains have been described in literature from universities like University of California, Davis and Cornell University, reflecting phylogenetic work involving collaborators at Smithsonian Institution and national agencies such as the United States Department of Agriculture.
The virion structure and replication strategy follow the retroviral paradigms characterized by researchers at Cold Spring Harbor Laboratory and Salk Institute, featuring an enveloped particle with a single-stranded positive-sense RNA genome reverse-transcribed by viral reverse transcriptase first elucidated by Howard Temin and David Baltimore. Genomic organization includes gag, pol, and env genes, with accessory elements and viral oncogenes (e.g., v-myc, v-mil) that were central to discoveries at Rockefeller University and documented in reports from National Institutes of Health. Comparative genomics leveraging methods developed at Genome Research Limited and European Molecular Biology Laboratory has revealed recombination events similar to those studied at Wellcome Trust Sanger Institute.
Natural hosts include domestic chickens, turkeys, and various wild avifauna monitored by organizations such as the Royal Society for the Protection of Birds, Audubon Society, and national wildlife services like the U.S. Fish and Wildlife Service. Experimental host range studies conducted at Istituto Zooprofilattico Sperimentale and veterinary colleges including University of Glasgow and University of Utrecht have demonstrated infection across multiple Galliformes and Anseriformes species, with occasional cross-species transmission evaluated in containment facilities at Centers for Disease Control and Prevention and veterinary institutes involved with World Organisation for Animal Health. Transmission occurs via vertical and horizontal routes, a subject addressed in policy contexts by agencies like the Food and Agriculture Organization and national ministries such as the Ministry of Agriculture, Fisheries and Food.
Infected birds develop proliferative lesions of myeloid and erythroid lineages, manifesting as palpable tumors, anemia, and immunosuppression, clinical features profiled in veterinary texts from Royal Veterinary College and case series from clinics at University of Sydney. The oncogenic mechanisms involve viral oncogenes analogous to those characterized in milestone studies at Harvard Medical School and University of Pennsylvania, linking viral transformation to signaling pathways explored in laboratories at Stanford University and University of Tokyo. Clinical signs such as lethargy, reduced egg production, and mortality have economic implications studied by institutions like University of Illinois Urbana-Champaign and Iowa State University.
Diagnostic approaches combine histopathology used in protocols from Mayo Clinic and Karolinska Institutet, serology techniques refined at Abbott Laboratories and Roche Diagnostics, and molecular assays—PCR and sequencing—developed at centers like Broad Institute and European Bioinformatics Institute. Virus isolation in cell culture follows methods standardized in manuals from World Organisation for Animal Health and laboratory networks including Veterinary Laboratories Agency, with electron microscopy contributed by facilities such as National Institutes of Health microscopy cores. Phylogenetic typing and genomic surveillance employ pipelines originating from Wellcome Trust Sanger Institute and bioinformatics approaches popularized at European Molecular Biology Laboratory.
There is no specific antiviral therapy; management emphasizes biosecurity practices endorsed by Food and Agriculture Organization and vaccination strategies informed by research at Cobb-Vantress and vaccine programs coordinated by agencies like United States Department of Agriculture and Defra. Breeding programs for resistance, diagnostics-driven culling, and disinfection protocols have been implemented under guidance from organizations such as World Organisation for Animal Health and national veterinary services including Agriculture and Agri-Food Canada. Experimental immunoprophylaxis and gene editing efforts for resistance draw on technologies advanced at CRISPR Therapeutics, Broad Institute, and research consortia involving Wellcome Trust funding.
The virus has historical importance in the discovery of oncogenes and reverse transcription, with landmark studies linked to laboratories at Rockefeller University, Cold Spring Harbor Laboratory, and investigators honored by awards like the Nobel Prize in Physiology or Medicine given to Howard Temin and David Baltimore. Research on the virus influenced cancer biology programs at Dana-Farber Cancer Institute and molecular oncology centers at Memorial Sloan Kettering Cancer Center, and continues to inform comparative oncology, virology, and vaccine science pursued at universities including Yale University and University of Oxford. Its legacy persists in collaborations among academic, governmental, and non-profit institutions such as National Academy of Sciences, Bill & Melinda Gates Foundation, and international research networks.
Category:Alpharetroviruses Category:Bird diseases Category:Oncoviruses